ArticleInfectious Disease Modelling2025
Dynamics of an SVEIR transmission model with protection awareness and two strains.
Article in Infectious Disease Modelling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Spatial heterogeneity and tendency prediction of a community transmission model with HIV detection.Infectious Disease Modelling · 2026Article
- Dynamic modelling and analysis of human brucellosis on age heterogeneity in Jinzhou, China.Infectious Disease Modelling · 2026Article
- Optimizing spatiotemporal nonpharmaceutical interventions for influenza: An adaptive reinforcement learning approach for regional heterogeneity.Infectious Disease Modelling · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As of May 2024, the main strains of COVID-19 caused hundreds of millions of infection cases and millions of deaths worldwide. In this study, we consider the COVID-19 epidemics with the main strains in the Chinese mainland. We study complex interactions among hosts, non-pharmaceutical interventions, and vaccinations for the main strains by a differential equation model called SVEIR. The disease transmission model incorporates two strains and protection awareness of the susceptible population. Results of this study show that the protection awareness plays a crucial role against infection of the population, and that the vaccines are effective against the circulation of the earlier strains, but ineffective for emerging strains. By using the next generation matrix method, the basic reproduction number of the SVEIR model is firstly obtained. Our analysis by Hurwitz criterion and LaSalle's invariance principle shows that the disease free-equilibrium point is locally and globally asymptotically stable when the threshold value is below one. The existences of endemic equilibrium points are also established, and the global asymptotic stabilities are analyzed using the Lyapunov function method. Further, the SVEIR model is confirmed to satisfy the principle of competitive exclusion, of which the strain with the larger value of the basic reproduction number is dominant. Numerically, the surveillance data with the Omicron strain and the XBB strain are split by the cubic spline interpolation method. The fitting curves against the surveillance data are plotted using the least-squares method from MATLAB. The results indicate that the XBB strain dominates in this study. Moreover, a global sensitivity analysis of the key parameters is performed by using of PRCC. The numerical simulations imply that combination control strategy positively impacts on the infection scale than what separate control strategy does, and that the earlier time producing protection awareness for the public creates less infection scale, further that the increment of protection awareness also reduces the infection scale. Therefore, the policymakers of the local government are suggested to concern the changes of protection awareness of the public.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.